The EMG GOLD Podcast is an educational and laid-back podcast which aims to provoke conversations with stakeholders in the pharmaceutical industry. This includes reporting on the latest trends and innovations, interviewing high-profile guests from the industry, and even guests from other industries that pharma can learn from. Join us for weekly insights and wisdom!
Massimiliano Siciliano on The Potential of Digital
18:05We talk to Massimiliano Siciliano, Digital Solution Director Europe, Novartis, about the potential of digital solutions for the pharmaceutical industry’s stakeholders and commercial teams, the technology he is most excited about within pharma’s digital revolution, and his three key principles for building high performing teams.
Clare Hague on Drug Pricing and Market Access
23:34We talk to Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen. She shares her perspective on the industry’s drug pricing challenges and opportunities, details alternative pricing systems that could improve access in low-to-middle-income countries, and explores the shifting market access landscape within oncology.
Pharma's Month in Review
6:48This week, we look back at the highlights in pharma throughout September, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing standouts, and the latest in research and development news.
Matt Atkinson and Megan Reutin on Reuters Events Pharma 2021
17:12We talk to Matt Atkinson, Global Projects Director, Reuters Events Pharma, and Megan Reutin, Global Head of Omnichannel Analytics, Grünenthal Group, about the upcoming Reuters Pharma 2021 Event. We get a sneak peek into the event's line-up, consider the future of virtual events, and explore the rapid digital transformation that has taken place over the past year.
Julie Ross on International Equal Pay Day
17:28We talk to Julie Ross, President, Advanced Clinical, about gender parity in the workplace in aid of International Equal Pay Day. In the discussion, she covers her journey to leadership, the importance of determination and resilience, and why gender parity in healthcare and life sciences is so essential.
Carol Lynch on Corporate Responsibility
21:17We talk to Carol Lynch, Chief Business Officer, Sandoz, about how to increase the number of women in leadership positions in the pharmaceutical industry, the importance of mental health provisions in the workplace, and Sandoz's role in increasing access to biosimilars around the world.
Keren Leshem on Running a Women’s Health Business
20:32We talk to Keren Leshem, Chief Executive Officer, OCON Healthcare about how she transformed OCON’s business strategy, the importance of educating women on their health and options, and how being mentored as well as acting as a mentor has shaped her career and outlook.
Pharma's Month in Review
5:45This week, we reflect on the highlights in pharma throughout August, covering the latest in COVID-19 therapy developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.
Edmond Chan on Improving Patient Outcomes
17:39This week, we talk to Edmond Chan, Senior Director, EMEA Therapeutic Area Lead, Haematology, Janssen, about the impact medical affairs can have on improving patient outcomes. He discusses the different approaches required to engage HCPs working in diabetes, immunology, and haematology, how to advance precision medicine, and steps that can be taken to improve the quality of life of those undergoing cancer treatment.
Dr Jerome Kim on Vaccines
33:23This week, we speak with Dr Jerome Kim, Director General, International Vaccine Institute, about vaccines. The conversation covers the nuances of the vaccine development process, the pharmaceutical industry's role in addressing vaccine hesitancy and refusal, and equitable distribution. He also shares his experience of working within the US military.